ASH 2011 Conference Coverage

Targeting AR Mutations Promising in Metastatic Prostate Cancer

A higher overall number of genetic alterations in cell-free circulating tumor DNA (ctDNA) were associated with worse treatment outcomes.

GUCS 2017: Early Immunotherapy Discontinuation in mRCC

Patients with advanced renal cell carcinoma (RCC) who discontinued anti-PD-1/PD-L1 immunotherapy early may still achieve durable responses.

Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer

Clinical trials show pembrolizumab active against mucosal melanoma, extends survival in bladder cancer.

Myalgia-arthralgia Syndrome Associated With Taxanes in Patients with Breast Cancer

[Breast Cancer: Targets and Therapy] This research examines predisposing factors, prevention, and therapy of myalgia-arthralgia syndrome (M-AS).

Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality

Risk for all-cause mortality is lower among older women treated for DCIS.

Metabolic Syndrome More Likely after Platinum-Based Chemotherapy for Testicular Cancer

Survivors of testicular cancer are more likely to develop metabolic syndrome after platinum-based chemotherapy.

Patient, Physician Preferences Inform Guidelines for Discussing Molecular Testing in Cancer Treatment

Study identifies physician and patient preferences about information, who should communicate this information, and what guidelines should guide these discussions.

Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline

Using statistical models, predictions were made for death rates from melanoma in 3 three countries and based on availability of a treatment.

Mammographic Breast Density Correlates With Risk of Primary, Contralateral Breast Cancer

High mammographic breast density is a risk factor for primary breast cancer. In this study, a potential correlation with contralateral breast cancer was investigated.

Treatment Outcomes Were Unchanged by Brentuximab Vedotin (BV)-induced Peripheral Neuropathy

Patients who were surveyed reported that the benefits of treatment with BV outweighed its risks.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs